SKB BIO Announces Investment in Structured Deposit Product

Stock News
06/03

SKB BIO (HKEX: 06990) has disclosed a new financial transaction. On June 3, 2026, the company entered into the China Zheshang Bank Structured Deposit Agreement IV. Under this agreement, SKB BIO has agreed to subscribe for a structured deposit from China Zheshang Bank with a principal amount of RMB 300 million.

As of the date of this announcement, the total outstanding principal amount of the company's wealth management products placed with China Zheshang Bank stands at RMB 590 million. This total comprises three specific structured deposits: (i) a RMB 100 million deposit under Structured Deposit Agreement II, details of which were provided in an April 2026 announcement; (ii) a RMB 190 million deposit under Structured Deposit Agreement III; and (iii) the newly announced RMB 300 million deposit under Structured Deposit Agreement IV.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10